UA90159C2 - Применение сложных эфиров гидроксибензойной кислоты и аналогов для получения лекарственного средства для предупреждения и лечения вирусной инфекции - Google Patents

Применение сложных эфиров гидроксибензойной кислоты и аналогов для получения лекарственного средства для предупреждения и лечения вирусной инфекции

Info

Publication number
UA90159C2
UA90159C2 UAA200802626A UAA200802626A UA90159C2 UA 90159 C2 UA90159 C2 UA 90159C2 UA A200802626 A UAA200802626 A UA A200802626A UA A200802626 A UAA200802626 A UA A200802626A UA 90159 C2 UA90159 C2 UA 90159C2
Authority
UA
Ukraine
Prior art keywords
analogues
acid ester
hydroxybenzoic acid
prevention
manufacture
Prior art date
Application number
UAA200802626A
Other languages
English (en)
Ukrainian (uk)
Inventor
Вейхуа Кин
Original Assignee
Шенгхуа (Гуанчжоу) Фармасьютикал Саенс Энд Текнолоджи Ко., Лтд
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шенгхуа (Гуанчжоу) Фармасьютикал Саенс Энд Текнолоджи Ко., Лтд filed Critical Шенгхуа (Гуанчжоу) Фармасьютикал Саенс Энд Текнолоджи Ко., Лтд
Publication of UA90159C2 publication Critical patent/UA90159C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

Применение сложного эфира гидроксибензойной кислоты и его аналогов для получения лекарственного средства для предупреждения и лечения вирусной инфекции, особенно для предупреждения у людей и животных инфекций HBV, HPV и HSV, где вирусная инфекция включает НВ, простой герпес, остроконечную кондилому, вагинит, цервицит и цервикальную эрозию.Другими словами, предусмотрены разные виды лекарственного средства и средства личной гигиены, которые получены с применением сложного эфира гидроксибензойной кислоты и аналогов и фармацевтического адъюванта.
UAA200802626A 2005-08-02 2006-07-21 Применение сложных эфиров гидроксибензойной кислоты и аналогов для получения лекарственного средства для предупреждения и лечения вирусной инфекции UA90159C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100122870A CN100427082C (zh) 2005-08-02 2005-08-02 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用

Publications (1)

Publication Number Publication Date
UA90159C2 true UA90159C2 (ru) 2010-04-12

Family

ID=37698614

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200802626A UA90159C2 (ru) 2005-08-02 2006-07-21 Применение сложных эфиров гидроксибензойной кислоты и аналогов для получения лекарственного средства для предупреждения и лечения вирусной инфекции

Country Status (22)

Country Link
EP (1) EP1930002B1 (ru)
JP (1) JP5473328B2 (ru)
KR (1) KR100922605B1 (ru)
CN (1) CN100427082C (ru)
AP (1) AP2658A (ru)
AU (1) AU2006275232B2 (ru)
BR (1) BRPI0616536B8 (ru)
CA (1) CA2617659C (ru)
CY (1) CY1117480T1 (ru)
DK (1) DK1930002T3 (ru)
EA (1) EA016576B1 (ru)
ES (1) ES2567130T3 (ru)
HK (1) HK1113747A1 (ru)
HU (1) HUE027244T2 (ru)
IL (1) IL189162A (ru)
MX (1) MX2008001673A (ru)
NZ (1) NZ566153A (ru)
PL (1) PL1930002T3 (ru)
SI (1) SI1930002T1 (ru)
UA (1) UA90159C2 (ru)
WO (1) WO2007014515A1 (ru)
ZA (1) ZA200801635B (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102603522B (zh) * 2011-01-23 2015-04-22 复旦大学 苯酚类衍生物及其在制备抗乙肝病毒药物中的用途
KR101401154B1 (ko) * 2011-02-22 2014-05-30 경희대학교 산학협력단 메틸 갈레이트를 포함하는 조절 ｔ 세포 활성 억제용 약학적 조성물
PL404138A1 (pl) * 2013-05-31 2014-12-08 Warszawski Uniwersytet Medyczny Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα
CN103599093B (zh) * 2013-11-18 2016-06-01 中国医学科学院生物医学工程研究所 一种抗hpv药物制剂及用途
CN104784323A (zh) * 2014-05-15 2015-07-22 刘善奎 一种治疗宫颈糜烂中药栓剂的制备方法
CN108463235A (zh) * 2015-12-18 2018-08-28 泰伦基国际有限公司 一种用于预防和治疗宫颈糜烂的方法
JP6793748B2 (ja) 2015-12-18 2020-12-02 タレンゲン インターナショナル リミテッドＴａｌｅｎｇｅｎ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｌｉｍｉｔｅｄ 放射性および化学的損傷を予防及び治療するための方法
CN105748506B (zh) * 2016-03-03 2018-08-17 青岛海洋生物医药研究院股份有限公司 褐藻酸硫酸酯在制备预防和治疗由人乳头瘤状病毒引起的疾病的药物和保健品中的应用
WO2019087881A1 (ja) * 2017-10-31 2019-05-09 富士フイルム株式会社 抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー
WO2019087884A1 (ja) * 2017-10-31 2019-05-09 富士フイルム株式会社 組成物、抗菌組成物、抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー
WO2019087888A1 (ja) * 2017-10-31 2019-05-09 富士フイルム株式会社 組成物、抗菌組成物、抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー
CN111419833B (zh) * 2020-06-02 2023-04-07 上海爱启医药技术有限公司 没食子酸的药物应用
CN112375803A (zh) * 2020-11-16 2021-02-19 石河子大学 五倍子中抗炎活性成分没食子酸乙酯的筛选方法及其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929985A (en) * 1974-01-18 1975-12-30 Richardson Merrell Inc Anhydrous candicidin foam compositions
JPS62132824A (ja) 1985-12-05 1987-06-16 Eisai Co Ltd 肝炎への治療剤
SE464167B (sv) * 1989-07-31 1991-03-18 Analytecon Sa Topisk farmaceutisk beredning av podophyllotoxin
CN1042298C (zh) * 1989-07-31 1999-03-03 安纳利蒂康有限公司 含鬼臼毒的乳膏形式的药物组合物的制备方法
CN1068782A (zh) * 1992-01-30 1993-02-10 展静 轮胎气压报警装置
NL9500216A (nl) * 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
DE19514694A1 (de) 1995-04-13 1996-10-17 Ina Dr Levi Breitspektrum-Antiinfektivamittel
JPH0959151A (ja) * 1995-08-24 1997-03-04 Kao Corp ＮＦ−κＢ活性化抑制剤
CN1068782C (zh) * 1996-04-18 2001-07-25 中国医药研究开发中心 以栾树提取物为有效组分的抗癌药物及制备方法
JPH09328404A (ja) * 1996-06-07 1997-12-22 Iwao Hishida 殺菌、抗菌および不活化剤
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
KR20010013377A (ko) 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
WO2002089818A1 (en) * 2001-05-03 2002-11-14 Farmigea S.P.A. Use of sucralfate for the treatment of cervical erosion

Also Published As

Publication number Publication date
NZ566153A (en) 2011-07-29
CN1907276A (zh) 2007-02-07
ZA200801635B (en) 2009-06-24
BRPI0616536B1 (pt) 2020-05-26
CA2617659C (en) 2013-02-26
EP1930002A1 (en) 2008-06-11
DK1930002T3 (en) 2016-04-11
HUE027244T2 (en) 2016-09-28
CA2617659A1 (en) 2007-02-08
AU2006275232B2 (en) 2010-12-02
BRPI0616536A2 (pt) 2012-12-25
EP1930002A4 (en) 2010-04-21
SI1930002T1 (sl) 2016-06-30
ES2567130T3 (es) 2016-04-20
EA016576B1 (ru) 2012-06-29
KR100922605B1 (ko) 2009-10-21
WO2007014515A1 (fr) 2007-02-08
AU2006275232A1 (en) 2007-02-08
IL189162A0 (en) 2008-08-07
KR20080036128A (ko) 2008-04-24
JP5473328B2 (ja) 2014-04-16
EA200800467A1 (ru) 2008-10-30
HK1113747A1 (zh) 2008-10-17
JP2009502985A (ja) 2009-01-29
CN100427082C (zh) 2008-10-22
AP2658A (en) 2013-05-09
MX2008001673A (es) 2008-11-06
CY1117480T1 (el) 2017-04-26
IL189162A (en) 2014-04-30
BRPI0616536B8 (pt) 2021-05-25
EP1930002B1 (en) 2016-01-06
PL1930002T3 (pl) 2016-07-29

Similar Documents

Publication Publication Date Title
UA90159C2 (ru) Применение сложных эфиров гидроксибензойной кислоты и аналогов для получения лекарственного средства для предупреждения и лечения вирусной инфекции
MX2012007410A (es) Compuestos antivirales novedosos.
NZ586751A (en) Use of CDDO methyl ester (methyl 2-cyano-3,12-dioxoleana-1,9(11)-dien-28-oate) for the treatment of renal diseases and for improving kigney function
WO2011005646A3 (en) Pharmaceutical composition for a hepatitis c viral protease inhibitor
MX2009012922A (es) Vacunacion intradermica de un peptido del virus del papiloma humano.
HK1152705A1 (en) Dihydropyrimidine compounds and use thereof for the treatment of viral diseases
WO2009024834A8 (en) Nucleic acids involved in viral infection
WO2007121895A3 (en) Hpv-16-based papillomavirus vaccine
WO2009148961A3 (en) Drugs to prevent hpv infection
WO2005084315A3 (en) Pyranoindole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease
RU2013148779A (ru) Лечение инфекции вируса гепатита в по отдельности или в комбинации с вирусом гепатита дельта и родственных заболеваний печени
SI1594885T1 (sl) Zdravilo za inhibiranje rasti tumorjev
MY144492A (en) Human papillomavirus vaccine comprising hpv 16 and hpv 18 virus like particles, which induce cross protection against other hpv types
WO2006076015A3 (en) 1-[2-(phosphonomethoxy)ethyl]-cytosine and analogs thereof
TW200501935A (en) Use of resveratrol for preparation of a medicament useful for the treatment of influenza virus infections
WO2006045616A3 (en) β-L-N4-HYDROXYCYTOSINE DEOXYNUCLEOSIDES AND THEIR USE AS PHARMACEUTICAL AGENTS IN THE PROPHYLAXIS OR THERAPY OF VIRAL DISEASES
IL203873A0 (en) Novel targets and compounds for therapeutic intervention of hiv infection
GEP20084377B (en) Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections
DE60305279D1 (de) Verwendung von Methyltestosteron zur Behandlung von menschlichen Papillomavirus Infektionen
WO2008154246A8 (en) Hiv integrase inhibitors
MD3121G2 (ru) Метод профилактики вирусного гепатита В
UA104484C2 (ru) Противовирусное средство множественного действия, состав и способ лечения вирусных заболеваний
WO2009030676A3 (en) Pharmaceutical composition comprising a japanese encephalitis virus for vaccination of patients of at least 40 years of age
MD3446G2 (ru) Метод лечения ВИЧ-инфекции
WO2009156162A8 (en) Genome wide visual identification of human co-factors of hiv-1 infection